Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety & Palliative Treatment Effect on Patients With Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT)

NCT02690428 is registered in ClinicalTrials.gov with Clinical Laserthermia Systems AB as lead sponsor.

NCT NCT02690428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02690428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety & Palliative Treatment Effect on Patients With Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT)
Lead sponsor
Clinical Laserthermia Systems AB
Phase
Not applicable
Overall status
Terminated
Start date
February 29, 2016
Completion date
April 30, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms